News | May 11, 2023
Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
The Awards recognizes standout digital health & medical technology products and companies
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Subscribe To Our Newsletter & Stay Updated
